Zobrazeno 1 - 10
of 88
pro vyhledávání: '"Kenta Motomura"'
Autor:
Akifumi Kuwano, Masayoshi Yada, Kazuki Kurosaka, Kosuke Tanaka, Akihide Masumoto, Kenta Motomura
Publikováno v:
JGH Open, Vol 7, Iss 2, Pp 98-104 (2023)
Abstract Background and Aim Direct‐acting antivirals (DAAs) have recently been developed to treat hepatitis C virus (HCV) infection. Additionally, interferon‐free DAA treatment has improved liver function and reduced the risk of hepatocellular ca
Externí odkaz:
https://doaj.org/article/04fbf6e554fa41ce866926d5ac88c275
Autor:
Junji Furuse, Namiki Izumi, Kenta Motomura, Yoshitaka Inaba, Yoshio Katamura, Yasuteru Kondo, Kazuhisa Yabushita, Katsuaki Motoyoshi, Masatoshi Kudo
Publikováno v:
Drugs - Real World Outcomes, Vol 10, Iss 2, Pp 195-205 (2023)
Abstract Background Lenvatinib was approved for use in unresectable hepatocellular carcinoma (uHCC) in Japan in 2018. Patients with diverse clinical characteristics receive lenvatinib treatment in clinical practice. Thus, it is crucial to evaluate th
Externí odkaz:
https://doaj.org/article/1586272cd8f54a5590c0cca0a2b18019
Publikováno v:
Gastro Hep Advances, Vol 2, Iss 5, Pp 621-622 (2023)
Externí odkaz:
https://doaj.org/article/40233e99e7eb49b89d6a306a4892ff3f
Autor:
Masatoshi Kudo, Kenta Motomura, Yoshiyuki Wada, Yoshitaka Inaba, Yasunari Sakamoto, Masayuki Kurosaki, Yoshiko Umeyama, Yoichi Kamei, Junichiro Yoshimitsu, Yosuke Fujii, Mana Aizawa, Paul B. Robbins, Junji Furuse
Publikováno v:
Liver Cancer, Pp 1-11 (2021)
Introduction: Combining an immune checkpoint inhibitor with a targeted antiangiogenic agent may leverage complementary mechanisms of action for the treatment of advanced/metastatic hepatocellular carcinoma (aHCC). Avelumab is a human anti-PD-L1 IgG1
Externí odkaz:
https://doaj.org/article/b8be2ef681554e6887c3892833ec2d08
Autor:
Yuka Oshikawa, Satoshi Fukushima, Taiga Miyake, Takeshi Kawaguchi, Kenta Motomura, Yasuhiro Nakashima, Kenichi Nakamura, Masatoshi Jinnin, Hironobu Ihn
Publikováno v:
Case Reports in Dermatology, Vol 4, Iss 2, Pp 144-149 (2012)
Late-onset erythropoietic protoporphyria (EPP) is rare, and it is usually associated with an acquired somatic mutation of the ferrochelatase gene secondary to hematological malignancy such as myelodysplastic syndrome or myeloproliferative disorder. I
Externí odkaz:
https://doaj.org/article/507664cc065b45b5aa982e1c32e8426a
Publikováno v:
Computational and Structural Biotechnology Journal, Vol 5, Iss 6 (2013)
Protein structure and function information is coded in amino acid sequences. However, the relationship between primary sequences and three-dimensional structures and functions remains enigmatic. Our approach to this fundamental biochemistry problem i
Externí odkaz:
https://doaj.org/article/de1a57684b1b4754876b52e2e19ec953
Autor:
Kenta Motomura, Tomohiro Fujita, Motosuke Tsutsumi, Satsuki Kikuzato, Morikazu Nakamura, Joji M Otaki
Publikováno v:
PLoS ONE, Vol 7, Iss 11, p e50039 (2012)
The amino acid sequences of proteins determine their three-dimensional structures and functions. However, how sequence information is related to structures and functions is still enigmatic. In this study, we show that at least a part of the sequence
Externí odkaz:
https://doaj.org/article/69640475a7e64675a31d1c645d27b861
Autor:
AKIFUMI KUWANO, SHIGEHIRO NAGASAWA, YUTA KOGA, KOSUKE TANAKA, MASAYOSHI YADA, AKIHIDE MASUMOTO, KENTA MOTOMURA
Publikováno v:
Experimental & Therapeutic Medicine; Sep2024, Vol. 28 Issue 3, p1-7, 7p
Autor:
AKIFUMI KUWANO, MASAYOSHI YADA, KOSUKE TANAKA, YUTA KOGA, SHIGEHIRO NAGASAWA, AKIHIDE MASUMOTO, KENTA MOTOMURA
Publikováno v:
In Vivo; Jul/Aug2024, Vol. 38 Issue 4, p1854-1858, 5p
Autor:
AKIFUMI KUWANO, MASAYOSHI YADA, KOSUKE TANAKA, YUTA KOGA, SHIGEHIRO NAGASAWA, AKIHIDE MASUMOTO, KENTA MOTOMURA
Publikováno v:
Cancer Diagnosis & Prognosis; Mar/Apr2024, Vol. 4 Issue 2, p111-116, 6p